Dr. Deborah R. Flomenhoft, MD

Dr. Flomenhoft practices at Lexington Surgery Center in Lexington, Kentucky.

Dr. Flomenhoft's NPI, 1619039781, was assigned on December 15, 2006. Dr. Flomenhoft graduated from University Of Kentucky College Of Medicine in 1998. Dr. Flomenhoft holds Kentucky license 35142.

Dr. Flomenhoft's primary practice is Lexington Surgery Center, at 2115 Harrodsburg Road, Lexington, KY 40504. The practice phone is (859) 276-2525.

Dr. Flomenhoft's primary practice is Lexington Surgery Center in Lexington, Kentucky. Dr. Flomenhoft is also affiliated with University of Kentucky Albert B. Chandler Hospital. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Flomenhoft to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flomenhoft practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Flomenhoft's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Flomenhoft is licensed in Kentucky.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Flomenhoft treats.

CMS data shows 331 Medicare services from Dr. Flomenhoft across 10 procedure codes in 2024, for 229 Medicare patients. Medicare paid $30,826 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 229 Medicare patients who saw Dr. Flomenhoft in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flomenhoft's median patient age at 57, with 62% women.

In 2024, Dr. Flomenhoft wrote 1,856 Medicare Part D claims for 340 patients. 55% of them were for generic drugs. CMS names the drug for 1,587 of them, across 44 drugs with 11 or more claims each, at $6,016,869 in total drug cost. In 2023, CMS named 1,138 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Flomenhoft for performance year 2024, reported as part of a group. Dr. Flomenhoft accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Flomenhoft as offering telehealth. CMS counts 64 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Flomenhoft, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Flomenhoft, published from 2020 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Crohn Disease and Kentucky. Dr. Flomenhoft has published most often in Inflamm Bowel Dis. Dr. Flomenhoft's most frequent co-authors are Terrence A. Barrett, MD, Mohammed Abdelsalam, MD and Waseem Ahmed, MD.

CMS Open Payments shows 38 general payments to Dr. Flomenhoft from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Janssen Pharmaceuticals, Inc paid the most, $11,137.

Dr. Flomenhoft graduated from University Of Kentucky College Of Medicine in 1998.

Dr. Flomenhoft is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.